Severe Acute Respiratory News and Research

RSS

The long-term clinical status of pediatric patients after testing positive for COVID-19

A recent study found that the most common long COVID symptoms in the pediatric population showed a higher prevalence among patients in the age range of 6-17 years and were identical to those reported in adults.

12 Sep 2022

SARS-CoV-2 Omicron BA.4.6 resistant to many therapeutic monoclonal antibodies in clinical use

In a recent study posted to the bioRxiv* preprint server, researchers in Taiwan and the United States explore the resistance of a newly emergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sub-variant BA.4.6 to the therapeutic monoclonal antibodies currently being used to treat coronavirus disease 2019 (COVID-19).

12 Sep 2022

Interferon response induced by Omicron BA.1 and BA.5 prevents influenza A infection

In a recent study posted to the bioRxiv* preprint server, researchers in Germany and the United Kingdom investigated the interferon responses induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant and SARS-CoV-2 Omicron sub-variants BA.1 and BA.5, and their efficacy in protecting cells from influenza A virus super-infection.

12 Sep 2022

Self-replicating intradermal RNA vaccine against SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, researchers assessed the efficiency of a controllable self-replicating ribonucleic acid (c-srRNA) vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

12 Sep 2022

Brain injury a common consequence of both COVID-19 and influenza

In a recent study published in the journal Brain, researchers reported that brain injury is common in coronavirus disease 2019 (COVID-19) and influenza.

12 Sep 2022

Antibody escape less pronounced with BA.2.75 compared to BA.4/5

In a recent study published in the Lancet, researchers evaluated the antibody neutralization sensitivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2.75 subvariant.

11 Sep 2022

Discovery of antibodies that may eliminate the need for COVID vaccines

...

11 Sep 2022

Climate change has increased the risk of bat-borne pathogen spillover

In a recent study posted to the bioRxiv* preprint server, researchers retrospectively assessed the association between climate change and disease spillover risks triggered by bat distribution changes based on historical climate and vampire-bat occurrence data for the previous century (1900-2020).

11 Sep 2022

Long COVID linked to persistence of SARS-CoV-2 spike protein in blood

A new study reports SARS-CoV-2 spike antigen and cytokine levels in a sample of infected individuals, of which a subset had long COVID.

11 Sep 2022

Factors influencing patient’s perception during COVID-19 recovery

A team of researchers characterized individual-level illness perception, both cognitive and emotional, following COVID-19.

9 Sep 2022

COVID-19’s long-term impact on orphanhood and caregiver loss

Researchers performed epidemiologic modeling to update COVID-19-associated caregiver and parent loss estimates.

9 Sep 2022

All SARS-CoV-2 variants neutralized by a potent new antibody

Researchers describe a mouse model used to generate a VH1-2 heavy chain (HC)- and Vκ1-33 light chain (LC)-based recombinant antibody that broadly neutralized all severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, including the newly emergent Omicron sub-variant BA.5.

9 Sep 2022

Supplementary folic acid associated with higher risk of COVID-19 diagnosis and mortality

In a recent study published in the journal BMJ Open, researchers investigated the impact of folic acid supplements and methotrexate, in combination or individually, on disease severity and mortality in coronavirus disease 2019 (COVID-19) cases.

8 Sep 2022

Significantly enlarged gray matter volume in neuropsychiatric long-COVID syndrome

In a recent study published in the journal Psychiatry Research, researchers found larger gray matter volumes (GMVs) in patients with neuropsychiatric long COVID syndrome.

8 Sep 2022

Can preclinical COVID-19 models help unlock mystery of long-COVID?

In a recently published article in the journal PLOS PATHOGENS, scientists have summarized acute and prolonged clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The review also provides an overview of the potency and utility of preclinical animal models to understand the mechanistic details of acute and long coronavirus disease 2019 (COVID-19).

8 Sep 2022

Severe Acute Respiratory News and Research

The long-term clinical status of pediatric patients after testing positive for COVID-19

SARS-CoV-2 Omicron BA.4.6 resistant to many therapeutic monoclonal antibodies in clinical use

Interferon response induced by Omicron BA.1 and BA.5 prevents influenza A infection

Self-replicating intradermal RNA vaccine against SARS-CoV-2

Brain injury a common consequence of both COVID-19 and influenza

Antibody escape less pronounced with BA.2.75 compared to BA.4/5

Discovery of antibodies that may eliminate the need for COVID vaccines

Climate change has increased the risk of bat-borne pathogen spillover

Long COVID linked to persistence of SARS-CoV-2 spike protein in blood

Factors influencing patient’s perception during COVID-19 recovery

COVID-19’s long-term impact on orphanhood and caregiver loss

All SARS-CoV-2 variants neutralized by a potent new antibody

Supplementary folic acid associated with higher risk of COVID-19 diagnosis and mortality

Significantly enlarged gray matter volume in neuropsychiatric long-COVID syndrome

Can preclinical COVID-19 models help unlock mystery of long-COVID?

Licorice compounds proposed as effective candidates for treatment of COVID-19

Biosynthetic proteins show promise as SARS-CoV-2 antivirals targeting spike protein

How does previous SARS-CoV-2 infection impact the B cell receptor repertoire in response to vaccination?

The role of some important antioxidants in major clinical outcomes of subjects with COVID-19

Plants and plant-derived preparations as co-treatments for COVID-19

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News